{{Rsnum
|rsid=6790433
|Gene=SLC6A6
|Chromosome=3
|position=14439270
|Orientation=plus
|GMAF=0.287
|Gene_s=SLC6A6
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 3.5 | 39.8 | 56.6
| HCB | 6.7 | 31.1 | 62.2
| JPT | 3.5 | 44.2 | 52.2
| YRI | 15.0 | 44.9 | 40.1
| ASW | 12.3 | 40.4 | 47.4
| CHB | 6.7 | 31.1 | 62.2
| CHD | 4.6 | 33.9 | 61.5
| GIH | 11.9 | 46.5 | 41.6
| LWK | 19.4 | 48.1 | 32.4
| MEX | 1.8 | 42.1 | 56.1
| MKK | 12.2 | 46.2 | 41.7
| TSI | 8.9 | 40.6 | 50.5
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23006423
  |Trait=Response to taxane treatment (docetaxel)
  |Title=Genetic association with overall survival of taxane-treated lung cancer patients - A genome-wide association study in human lymphoblastoid cell lines followed by a clinical association study.
  |RiskAllele=
  |Pval=1E-6
  |OR=NR
  |ORtxt=NR
  |OA=1
}}

{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}